Methyl-Cyclopentadienyl Ruthenium Compounds With 2,2-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential

doi 10.1021/acs.inorgchem.8b00358.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)


Related search